The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Low-dose, short-course sunitinib may normalize tumor vasculature and improve tumor blood flow to enhance chemotherapy efficacy in breast cancers.
Soo-Chin Lee
No relevant relationships to disclose
Andrea LA Wong
No relevant relationships to disclose
Thian C Ng
No relevant relationships to disclose
Choon Hua Thng
No relevant relationships to disclose
Ting Ting Wang
No relevant relationships to disclose
Maricel Cordero Tiemsim
No relevant relationships to disclose
Eugene Ong
No relevant relationships to disclose
Tong San Koh
No relevant relationships to disclose
Dennis Cheong
No relevant relationships to disclose
Pei-Jye Voon
No relevant relationships to disclose
I Peng Thomas Soh
No relevant relationships to disclose
Ching-Wan Chan
No relevant relationships to disclose
Philip Iau
No relevant relationships to disclose
Chee Seng Tan
No relevant relationships to disclose
Angela Pang
No relevant relationships to disclose
Boon C. Goh
No relevant relationships to disclose